Laurus Labs Ltd

Surging past the Rs 1980 mark, Laurus Labs Ltd has reached a fresh 52-week high on 11 Sep 2026, extending its remarkable rally that has more than doubled the stock price from Rs 822.85 over the past year. This milestone comes amid a backdrop of strong technical momentum and sustained upward price action, even as the broader market struggles to maintain its footing.

Extending its winning streak to two sessions, Laurus Labs Ltd surged 2.16% on 11 Sep 2026 to touch a fresh all-time high of Rs 1,980.65, narrowly missing its 52-week peak by just 0.38%. This rally comes amid broad-based outperformance, with the stock significantly outpacing the Sensex, which slipped 0.07% on the same day.

Laurus Labs Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 30 April 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 11 September 2026, providing investors with the most up-to-date view of the company’s performance and outlook.

Surging past its previous peaks, Laurus Labs Ltd touched a fresh 52-week high of Rs 1981 on 10 Sep 2026, marking a remarkable 116.76% gain over the past year. This milestone comes amid a backdrop of strong technical momentum and sustained earnings growth, setting the stage for a compelling price rally that has outpaced the broader market.

Extending its remarkable rally, Laurus Labs Ltd touched a fresh all-time high of Rs 1,944.45 on 10 Sep 2026, continuing to outpace the broader market and its sector peers with sustained momentum across multiple timeframes.

Surging past its previous peaks, Laurus Labs Ltd touched a new 52-week high of Rs 1955 on 09 Sep 2026, marking a remarkable 115.13% gain over the past year. This milestone comes amid a backdrop of strong technical momentum, even as the broader Sensex struggles near its own lows.

Extending its winning streak to three sessions, Laurus Labs Ltd touched a fresh all-time high of Rs 1,954 on 09 Sep 2026, outpacing the broader Sensex which declined 0.67% on the day.

Surging past its previous peaks, Laurus Labs Ltd reached a fresh 52-week high of Rs 1949.4 on 8 Sep 2026, marking a remarkable 117.56% gain over the past year. This milestone comes amid a backdrop of strong technical momentum and sustained price strength, even as the broader market indices have struggled.

Laurus Labs Ltd, a prominent player in the Pharmaceuticals & Biotechnology sector, reached a new all-time high of Rs. 1,949.40 on 8 September 2026, marking a significant milestone in its market journey. The stock’s robust performance has been underscored by strong financial results and sustained upward momentum, reflecting the company’s operational strength and investor confidence.

Laurus Labs Ltd, a mid-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a significant 25.2% surge in open interest in its derivatives segment, signalling heightened market activity despite the stock’s recent underperformance. This development comes amid a two-day consecutive decline in the stock price, raising questions about evolving market positioning and potential directional bets by investors.

Laurus Labs Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 30 April 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 31 August 2026, providing investors with the most up-to-date insight into the company’s performance and outlook.

Laurus Labs Ltd, a prominent player in the Pharmaceuticals & Biotechnology sector, witnessed significant trading activity on 31 Aug 2026, with value turnover nearing ₹160 crores. Despite a slight dip in price, the stock remains close to its 52-week high, reflecting sustained investor interest amid a cautious market backdrop.

Surging past Rs 1947.9 on 31 Aug 2026, Laurus Labs Ltd has marked a significant milestone by reaching a fresh 52-week high, extending its remarkable 122.16% rally over the past year. This price peak comes amid a backdrop of strong technical momentum, even as the broader Sensex struggles with a three-week decline.

Laurus Labs Ltd, a prominent player in the Pharmaceuticals & Biotechnology sector, reached a significant milestone on 31 August 2026 by touching its all-time high stock price of Rs.1,947.90. This achievement marks a culmination of sustained strong performance and robust financial metrics, underscoring the company’s position as a reliable mid-cap stock with a solid track record.

Surging to a new 52-week and all-time high of Rs 1939 on 28 Aug 2026, Laurus Labs Ltd has demonstrated remarkable price momentum, outperforming the broader market with a 122.35% gain over the past year against the Sensex’s decline of 3.55%. This milestone caps a four-day winning streak that has propelled the stock 6.9% higher, underscoring the strength of its technical setup amid a cautiously optimistic market backdrop.

Laurus Labs Ltd, a prominent player in the Pharmaceuticals & Biotechnology sector, reached a significant milestone on 28 August 2026, with its stock price touching an all-time high of Rs.1939. This achievement marks a culmination of sustained strong performance and robust financial metrics that have propelled the stock to new heights.

With a remarkable ascent from Rs 822.85 to Rs 1903 over the past year, Laurus Labs Ltd has more than doubled its share price, culminating in a fresh 52-week high on 27 Aug 2026. This milestone reflects a confluence of strong technical momentum and sustained price strength, setting the stage for further market attention.